CYTK position history
The shares of Cytokinetics (CYTK) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 175,000 shares, $6.3M, 1.7% of portfolio
- 2021 Q4: 134,094 shares, $6.1M, 1.5% of portfolio, Reduce −23.4%
- 2022 Q1: 211,495 shares, $7.8M, 2.0% of portfolio, Add +57.7%
- 2022 Q2: 211,495 shares, $8.3M, 2.3% of portfolio
- 2022 Q3: 183,995 shares, $8.9M, 2.4% of portfolio, Reduce −13.0%
- 2022 Q4: 183,995 shares, $8.4M, 2.4% of portfolio
- 2023 Q1: 276,495 shares, $9.7M, 2.9% of portfolio, Add +50.3%
- 2023 Q2: 332,734 shares, $11M, 3.0% of portfolio, Add +20.3%
- 2023 Q3: 479,538 shares, $14M, 4.4% of portfolio, Add +44.1%
- 2023 Q4: 400,000 shares, $33M, 8.0% of portfolio, Reduce −16.6%
- 2024 Q1: 398,100 shares, $28M, 6.4% of portfolio, Reduce −0.5%
- 2024 Q2: 398,100 shares, $22M, 5.2% of portfolio
- 2024 Q3: 398,100 shares, $21M, 5.0% of portfolio
- 2024 Q4: 398,100 shares, $19M, 4.8% of portfolio
- 2025 Q1: 398,100 shares, $16M, 4.5% of portfolio
- 2025 Q2: 398,100 shares, $13M, 3.6% of portfolio
- 2025 Q3: 394,940 shares, $22M, 5.4% of portfolio, Reduce −0.8%
- 2025 Q4: 370,997 shares, $24M, 5.5% of portfolio, Reduce −6.1%
- 2026 Q1: 217,497 shares, $14M, 3.3% of portfolio, Reduce −41.4%
- 2026 Q2: 171,998 shares, $15M, 2.8% of portfolio, Reduce −20.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|